Sibling Bullying Tied to Increased Odds of Psychotic Disorder
TUESDAY, Feb. 20, 2018 -- Children involved in sibling bullying are at increased risk of developing a psychotic disorder, according to a study published online Feb. 12 in Psychological Medicine.
Slava Dantchev, from the University of Warwick in the United Kingdom, and colleagues examined 6,988 participants of a U.K. community-based birth cohort. Sibling bullying was reported at 12 years, and psychotic disorder was assessed at age 18 years via semi-structured interview.
The researchers found that even after adjustment for a range of confounders, there was a correlation for involvement in sibling bullying with psychotic disorder in a dose-response manner. The likelihood of meeting the criteria for a psychotic disorder was increased two- to three-fold for those involved in sibling bullying several times a week (odds ratios: 2.74 for victimization, 3.16 for perpetration). In categorical analysis, the risk of psychotic disorder was increased for victims (odds ratio, 3.1) and bully-victims (odds ratio, 2.66). There was a dose-effect relationship for involvement in both sibling and peer bullying, with those victimized in both contexts experiencing even greater odds for psychotic disorder (odds ratio, 4.57).
"Our study adds that children involved in sibling bullying are at increased risk of developing a psychotic disorder, in keeping with findings for other kinds of stressors during childhood," the authors write. "If causal, as suggested by our study, this highlights the need for parents and health professionals to identify and put into place mechanisms to minimize sibling bullying within families."
© 2020 HealthDay. All rights reserved.
Posted: February 2018
More News Resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
- Monthly Update Archive
Subscribe to our Newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.